Usana Health Sciences Inc
USNA
Get informed when a big investor buys or sells
+ FollowMarket Cap$270.67M
Close$
$60.13
291% upside
Current Fair Value
291% upsideUndervalued by 291% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $270.67 Million |
|---|---|
| Enterprise Value | $102.11 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.58 |
| Beta | 0.68 |
| Outstanding Shares | 18,486,000 |
Return
| Return on Equity | -4.21% |
|---|---|
| Return on Assets | -3.15% |
| Return on Invested Capital | 2.35% |
Valuation & Multiples
| P/E Ratio | -12.15 |
|---|---|
| PEG | 3.78 |
| Price to Sales | 0.31 |
| Price to Book Ratio | 0.51 |
| Enterprise Value to Revenue | 0.11 |
| Enterprise Value to EBIT | 7.26 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 4, 2026
EPS Estimate
$0.43
Average shareholder expectationRevenue Estimate
$235.00 M
Average shareholder expectationNext Earnings Call
Expected Date
October 28, 2026
EPS Estimate
$0.11
Average shareholder expectationRevenue Estimate
$217.42 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 130.47% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.03%▼ 63.04% |
|---|---|
| Total Invested | $72,061▼ 99.97% |
| Investors Holding | 4▼ 136.00% |
ESG Score
No data
About Usana Health Sciences Inc
CEO: Kevin Guest